Vanguard Group Inc Evolus, Inc. Transaction History
Vanguard Group Inc
- $4.96 Trillion
- Q1 2024
A detailed history of Vanguard Group Inc transactions in Evolus, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 2,905,510 shares of EOLS stock, worth $30.4 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,905,510
Previous 2,943,512
1.29%
Holding current value
$30.4 Million
Previous $31 Million
31.24%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding EOLS
# of Institutions
173Shares Held
47MCall Options Held
720KPut Options Held
532K-
Perceptive Advisors LLC New York, NY5.75MShares$60.1 Million1.69% of portfolio
-
Tang Capital Management LLC San Diego, CA4.15MShares$43.3 Million7.07% of portfolio
-
Black Rock Inc. New York, NY3.26MShares$34.1 Million0.0% of portfolio
-
Morgan Stanley New York, NY3.04MShares$31.8 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT2.91MShares$30.4 Million2.62% of portfolio
About Evolus, Inc.
- Ticker EOLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 56,094,800
- Market Cap $586M
- Description
- Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...